Development of a new generation of pediatric mRNA vaccins, capable of activating cytological T cells against the four serotypes of dengue virus, thus preventing the risk of Antibody Dependent Enhancement (ADE).
| Website | http://www.v-4-c.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2022 |
| Address | Rue du Faubourg Saint-Jacques, 24, Paris, Île-de-France 75014, FR |
| Industry | Biotechnology Research |
| Keywords | Pediatric Vaccines, Vaccine Development, Vaccine Research, Childhood Immunizations, Mrna Technology, Viral Vaccines, Infectious Disease, Drug Development, Pharmaceutical Research, Novel Vaccines, Immunotherapy, Biotechnology, Preventative Medicine, Immunology, Viral Vector Vaccines, Clinical Trials, Public Health |
Looking for a particular V4C employee's phone or email?
V4C Questions
Brad Schneider is the CEO of V4C.
1 people are employed at V4C.
V4C is based in Paris, Île-de-France.
Top V4C Employees
-
Brad Schneider
Chief Executive Officer at V4C
California, United States23
G2Crowd Trusted
300K+
Plugin Users
